(VIANEWS) – Shares of FibroGen (FGEN) dropped by a staggering 50.02% in 30 days from $26.01 to $13.00 at 12:17 EST on Saturday, following the last session’s downward trend. NASDAQ Composite is falling 0.71% to $14,672.68, following the last session’s downward trend.
FibroGen’s last close was $12.84, 77.56% below its 52-week high of $57.21.
Today’s last reported volume for FibroGen is 712016 which is 43.52% below its average volume of 1260611.
The company’s growth estimates for the current quarter is 52.6% and a drop 60% for the next.
Year-on-year quarterly revenue growth grew by 57.5%, now sitting on 190.35M for the twelve trailing months.
FibroGen’s last week, last month’s, and last quarter’s current volatility was a negative 0.62%, a negative 4.70%, and a positive 3.68%, respectively.
FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.62% (last week), 6.20% (last month), and 3.68% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
FibroGen’s stock is considered to be overbought (>=80).
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $13.00 at 12:17 EST, way below its 52-week high of $57.21 and higher than its 52-week low of $12.54.
FibroGen’s Moving Average
FibroGen’s value is way under its 50-day moving average of $23.02 and way below its 200-day moving average of $30.70.
More news about FibroGen (FGEN).